Clinical pharmacist-led antifungal drug utilization reviews in cancer care hospital: a prospective audit and feedback
2024

Pharmacist-led antifungal reviews in cancer care

Sample size: 350 publication Evidence: high

Author Information

Author(s): Akbar Zunaira, Aamir Muhammad, Saleem Zikria, Khan Muhammad Rehan, Bhutta Omar Akhlaq

Primary Institution: Shaukat Khanum Memorial Cancer Hospital and Research Centre

Hypothesis

The study aimed to evaluate the effectiveness of clinical pharmacist-led antifungal drug utilization reviews in optimizing antifungal therapy in cancer patients.

Conclusion

Pharmacists significantly improve antifungal therapy management through targeted interventions in cancer patients.

Supporting Evidence

  • Pharmacists conducted drug utilization reviews for 350 cancer patients.
  • 100% of pharmacist interventions were accepted by the AFS team.
  • Most patients were prescribed antifungals for suspected fungal infections.

Takeaway

Pharmacists help make sure cancer patients get the right antifungal medicines, which can make them feel better and avoid side effects.

Methodology

A prospective audit and feedback study was conducted, reviewing electronic medical records of 350 cancer patients prescribed systemic antifungals.

Limitations

The study focused only on cancer patients with systemic fungal infections and could not ascertain the effects of pharmacist interventions on mortality or length of hospital stay.

Participant Demographics

{"gender":{"male":218,"female":132},"age_group":{"adult":177,"paediatric":173},"weight":{"over_45kg":155,"under_15kg":93,"16_to_30kg":55,"31_to_45kg":47},"type_of_cancer":{"leukaemia":168,"lymphoma":80,"carcinoma":33,"sarcoma":26,"others":43},"febrile_neutropenia":194}

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/jacamr/dlae184

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication